Analysis on Cost-Effect of Three TCM Injections for the Treatment of Stroke
10.3969/j.issn.1005-5304.2015.03.033
- VernacularTitle:3种中药注射剂治疗中风方案成本-效果分析
- Author:
Hui WANG
;
Ting LI
;
Wen ZUO
;
Yan GE
- Publication Type:Journal Article
- Keywords:
stroke;
TCM injections cost-effect analysis;
pharmacoeconomics
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2015;(3):115-116
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy and carry out analysis on pharmacoeconomic cost-effect of three therapeutic schemes in the treatment for stroke. Methods Through a retrospective survey method, 115 stroke patients, based on different treatment methods, were divided into 3 groups:Xuesaitong group (A), carthamin yellow group (B), and Xueshuantong group (C). An analysis on pharmacoeconomic cost-effect was conducted. Results The costs of three therapeutic schemes were 1030.4 yuan, 1876 yuan, and 1545.6 yuan, respectively. The total effective rates of stroke patients in groups A, B and C were 85.37%, 88.57% and 90.04%, respectively. The cost-effect ratios of groups A, B and C were 12.07, 21.18, and 17.17. The added cost-effect ratios of groups B and C compared with group A were 264.25 and 110.32, respectively. Conclusion Xueshuantong Injection has more pharmacoeconomic advantage than Xuesaitong and carthamin yellow Injections in treating stroke.